RxDoctor Payments Data

Mary Quarterman

Internal Medicine · Orlando, FLNPI 1487974762

Payments from drug & device makers

$1,415,236in general payments, 2019–2025

Across 460 payments — averaging $3076.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim International GmbH$671K
  • Eli Lilly$638K
  • Regeneron$103K
  • Astrazeneca UK Limited$2K
  • Novo Nordisk$167
  • Pfizer$157
  • plus $643 from 14 others

What the payments were for

  • Travel & lodging$6,87737%
  • Food & beverage$11,64763%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,415,236 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
Losartan Potassium13$100
Levothyroxine Sodium12$85
Zolpidem Tartrate12$84
Pantoprazole Sodium12$77
Quetiapine Fumarate12$76

Paid to pharmacies, not to this prescriber.

Other internal medicine in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →